title: Injection of colon carcinoma patients with autologous irradiated tumor cells and fibroblasts genetically modified to secrete interleukin-2 (IL-2): a phase I study.
authors.affiliation: San Diego Regional Cancer Center, CA 92121, USA.
authors.forename: R E
authors.initials: RE
authors.lastname: Sobol
authors.forename: I
authors.initials: I
authors.lastname: Royston
authors.forename: H
authors.initials: H
authors.lastname: Fakhrai
authors.forename: D L
authors.initials: DL
authors.lastname: Shawler
authors.forename: C
authors.initials: C
authors.lastname: Carson
authors.forename: O
authors.initials: O
authors.lastname: Dorigo
authors.forename: R
authors.initials: R
authors.lastname: Gjerset
authors.forename: D P
authors.initials: DP
authors.lastname: Gold
authors.forename: J
authors.initials: J
authors.lastname: Koziol
authors.forename: D
authors.initials: D
authors.lastname: Mercola
mesh_terms: D017690:Cell Transplantation; D002985:Clinical Protocols; D017321:Clinical Trials, Phase I as Topic; D003110:Colonic Neoplasms / Q000628:therapy*; D005347:Fibroblasts; D018014:Gene Transfer Techniques / Q000009:adverse effects; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D007258:Informed Consent; D007376:Interleukin-2 / Q000235:genetics* / Q000627:therapeutic use
chemical_list: D007376:Interleukin-2